AIML.CN Stock Trades at C$0.035 on CNQ Exchange, April 2026

AI/ML Innovations Inc. (AIML.CN) trades at C$0.035 on the CNQ exchange as of April 28, 2026. The healthcare technology company operates in digital health monitoring and wearable systems. AIML.CN stock has declined significantly, down 61% over the past year and 95% over five years. The company carries a market cap of C$5.89 million with 168.3 million shares outstanding. Meyka AI rates AIML.CN stock with a grade of C+, suggesting a HOLD position. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

AIML.CN Stock Performance and Valuation Metrics

AIML.CN stock has faced severe headwinds in recent years. The stock trades at C$0.035, unchanged from the previous close, with a 52-week range between C$0.03 and C$0.12. Year-to-date performance data remains unavailable, but the five-year decline of 95% reflects persistent challenges.

Valuation metrics paint a concerning picture for AIML.CN stock. The price-to-sales ratio stands at 46.94x, indicating the market values the company at nearly 47 times its annual revenue. The price-to-book ratio reaches 35.17x, suggesting significant premium pricing relative to tangible assets. With negative earnings per share of C$-0.03 and a PE ratio of -1.26, traditional valuation methods become unreliable. Track AIML.CN on Meyka for real-time updates on these metrics.

Financial Health and Cash Flow Challenges

AIML.CN stock reflects a company struggling with profitability and cash generation. The company reports negative operating cash flow of C$-0.021 per share and negative free cash flow of C$-0.021 per share. Net profit margin sits at a deeply negative 56.2%, meaning the company loses money on every dollar of revenue generated.

Liquidity concerns emerge from a current ratio of 0.76, below the healthy 1.0 threshold. This indicates AIML.CN may struggle to meet short-term obligations. Return on equity stands at negative 5.05%, while return on assets registers at negative 4.34%. The company carries debt-to-equity of 0.72, adding financial pressure during unprofitable operations. These metrics suggest AIML.CN stock faces structural challenges beyond temporary market conditions.

Market Sentiment and Technical Indicators

Technical analysis of AIML.CN stock reveals mixed signals with concerning volume patterns. The Relative Strength Index (RSI) reads 47.27, indicating neutral momentum without clear directional bias. The Money Flow Index (MFI) shows 84.56, suggesting overbought conditions despite minimal price movement. Daily volume of 2,378 shares represents just 0.61% of the 388,531-share average, indicating extremely thin trading liquidity.

The Stochastic oscillator shows %K at 66.67 and %D at 61.11, both in overbought territory. Bollinger Bands remain tight between C$0.03 and C$0.04, reflecting low volatility. The Average True Range (ATR) of 0.00 confirms minimal price fluctuation. These technical conditions suggest AIML.CN stock lacks the trading activity and price discovery mechanisms typical of liquid equities, creating execution risk for investors.

Company Operations and Market Position

AI/ML Innovations Inc. operates in the Medical – Healthcare Information Services industry within the Healthcare sector. The Victoria, British Columbia-based company focuses on patent-pending personal health monitoring systems for caregivers, patients, and healthcare professionals. CEO John Paul Duffy leads operations at 645 Fort Street, Victoria, BC V8W 1G2.

The company was formerly known as AIML Resources Inc. before rebranding in November 2020. Despite operating in the growing digital health space, AIML.CN stock reflects market skepticism about execution and commercialization. Revenue per share of C$0.00049 demonstrates minimal sales generation relative to the company’s cost structure. The company’s inability to achieve profitability or positive cash flow raises questions about business model viability and competitive positioning within healthcare technology.

Final Thoughts

AIML.CN stock presents a high-risk profile for investors. Trading at C$0.035 with a C+ grade from Meyka AI, the company faces significant operational and financial challenges. Negative profitability, negative cash flow, and extremely thin trading volume create substantial headwinds. The 95% five-year decline reflects persistent market skepticism about the company’s ability to execute its digital health strategy. Investors should conduct thorough due diligence before considering AIML.CN stock, given the structural challenges evident in financial metrics and market activity. The company’s position in the growing healthcare technology sector offers potential, but current fundamentals suggest substantial risk remains.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.